IP Library Granted Patent US 12,359,376
Granted Patent B2
US 12,359,376 · App. 17/936,535 · Granted Jul 15, 2025

Creped fibrous structures

Inventors: Fei Wang (Mason, OH); Douglas Jay Barkey (Salem Township, OH); James Allen Cain (Albany, NY); Stephen John Delvecchio (Cincinnati, OH); Angela Marie Leimbach (Hamilton, OH); Kun Piao (Deerfield Township, OH); James Kenneth Comer (West Chester, OH); Ryan Dominic Maladen (Anderson Township, OH); Atiya Jordan-Brown (Lebanon, OH); David Warren Loebker (Cincinnati, OH)
Assignee: The Procter & Gamble Company
D21H27/02D21F1/10D21F5/048D21F5/181D21F9/02D21F11/006D21H21/146D21H25/005D21H27/002D21H27/004D21H27/005D21H27/007D21H27/008D21H27/40B31F1/126B31F1/16D21F3/045D21F5/188D21G3/005D21H21/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,359,376
App. No.
17/936,535
Granted
Jul 15, 2025
Kind
B2
Abstract

Creped fibrous structures having pillows and knuckles, wherein the creped fibrous structures may exhibit improved knuckle properties, such as Knuckle Roughness Ra, Knuckle Roughness Rq, and Knuckle Creping Frequency and methods for making same are provided, and/or may comprise elongate knuckles comprising discrete pillows and/or elongate pillows between first and second elongate knuckles.

Claims (17)

1. A creped fibrous structure, comprising:

an elongate knuckle comprising a perimeter;

a first pillow and a second pillow;

wherein the first and second pillows are discrete from each other;

wherein the first pillow exhibits a bulk building capability of greater than 16 cc/g; and

wherein the creped fibrous structure has a Knuckle Roughness Ra of less than 9.00 μm as measured according to the MikroCAD Test Method.

2. The fibrous structure according to claim 1 , wherein the first pillow exhibits a bulk building capability of greater than 17 cc/g.

3. The fibrous structure according to claim 1 , wherein the fibrous structure exhibits a wet caliper normalized for basis weight of greater than 0.65 mils/(lb./3000 ft 2 ) as measured according to the Caliper Test Method.

4. The fibrous structure according to claim 1 , wherein the fibrous structure is in roll form such that the roll of fibrous structure exhibits a Roll Compressibility of from about 0.5% to about 15% as measured according to the Roll Compressibility Test Method.

5. The fibrous structure according to claim 1 , wherein the fibrous structure is in roll form such that the roll of fibrous structure exhibits a Roll Firmness of from about 2.5 mm to about 15 mm as measured according to the Roll Firmness Test Method.

6. The fibrous structure according to claim 1 , wherein the fibrous structure is in roll form such that the roll of fibrous structure exhibits a Roll Compressibility of from about 0.5% to about 15% as measured according to the Roll Compressibility Test Method, a roll bulk of about 4 cm 3 /g to about 30 cm 3 /g, and a Roll Firmness of from about 2.5 mm to about 15 mm as measured according to the Roll Firmness Test Method.

7. The creped fibrous structure according to claim 1 , comprising a basis weight of from 50 g/m 2 (30.8 lbs/3000 ft 2 ) to 110 g/m 2 (67.7 lbs/3000 ft 2 ).

8. The creped fibrous structure according to claim 1 , comprising a Knuckle Creping Frequency of less than 5.5 #/mm as measured by the MikroCAD Test Method.

9. The fibrous structure according to claim 1 , wherein each of the first and second pillows are within the perimeter of the elongate knuckle.

10. The fibrous structure according to claim 1 , exhibiting a basis weight of from about 55 g/m 2 (33.8 lbs/3000 ft 2 ) to about 105 g/m 2 (64.6 lbs/3000 ft 2 ).

11. The fibrous structure according to claim 1 , exhibiting a basis weight of from about 60 g/m 2 (36.9 lbs/3000 ft 2 ) to about 100 g/m 2 (61.5 lbs/3000 ft 2 ).

12. The fibrous structure according to claim 1 , exhibiting a Knuckle Roughness Rq of less than 8.00 μm.

Continuity (5)
Continuation 16938123 · Jul 24, 2020
Continuation 15792824 · Oct 25, 2017
Provisional Application 62489007 · Apr 24, 2017
Provisional Application 62412455 · Oct 25, 2016
Related Publication 20230027102A1 · Jan 26, 2023
References Cited (204)
US 2742823A · Compton · 1956 [cited by applicant]
US 2834828A · Ebel · 1958 [cited by applicant]
US 2946725A · Norris · 1960 [cited by applicant]
US 3070510A · Cooley · 1962 [cited by applicant]
US 3111127A · Jarboe · 1963 [cited by applicant]
US 3535421A · Briner · 1970 [cited by applicant]
US 3538230A · Pader · 1970 [cited by applicant]
US 3678154A · Widder · 1972 [cited by applicant]
US 3862307A · Di Giulio · 1975 [cited by applicant]
US 3917613A · Humbert et al. · 1975 [cited by applicant]
US 3991178A · Humbert et al. · 1976 [cited by applicant]
US 4029759A · Humbert et al. · 1977 [cited by applicant]
US 4051234A · Gieske · 1977 [cited by applicant]
US 4070496A · Rowsell et al. · 1978 [cited by applicant]
US 4136163A · Watson · 1979 [cited by applicant]
US 4150052A · Watson · 1979 [cited by applicant]
US 4153679A · Rowsell · 1979 [cited by applicant]
US 4157384A · Browning · 1979 [cited by applicant]
US 4178459A · Rowsell · 1979 [cited by applicant]
US 4206215A · Bailey · 1980 [cited by applicant]
US 4230688A · Rowsell · 1980 [cited by applicant]
US 4340583A · Wason · 1982 [cited by applicant]
US 4459425A · Amano · 1984 [cited by applicant]
US 4514345A · Johnson et al. · 1985 [cited by applicant]
US 4966754A · Purohit et al. · 1990 [cited by applicant]
US 5004597A · Majeti · 1991 [cited by applicant]
US 5180577A · Polefka · 1993 [cited by applicant]
US 5266592A · Grub et al. · 1993 [cited by applicant]
US 5281410A · Lukacovic · 1994 [cited by applicant]
US 5322689A · Hughes et al. · 1994 [cited by applicant]
US 5328565A · Rasch et al. · 1994 [cited by applicant]
US 5399412A · Sudall et al. · 1995 [cited by applicant]
US 5451404A · Furman · 1995 [cited by applicant]
US 5503715A · Trokhan et al. · 1996 [cited by applicant]
US 5578293A · Prencipe · 1996 [cited by applicant]
US 5589160A · Rice · 1996 [cited by applicant]
US 5603920A · Rice · 1997 [cited by applicant]
US 5608119A · Amano et al. · 1997 [cited by applicant]
US 5628876A · Ayers et al. · 1997 [cited by applicant]
US 5637194A · Ampulski et al. · 1997 [cited by applicant]
US 5651958A · Rice · 1997 [cited by applicant]
US 5658553A · Rice · 1997 [cited by applicant]
US 5703123A · Pelzer et al. · 1997 [cited by applicant]
US 5714041A · Ayers et al. · 1998 [cited by applicant]
US 5716601A · Rice · 1998 [cited by applicant]
US 5725865A · Mane et al. · 1998 [cited by applicant]
US 5843466A · Mane et al. · 1998 [cited by applicant]
US 5904811A · Ampulski et al. · 1999 [cited by applicant]
US 5977166A · Greenberg · 1999 [cited by applicant]
US 6117270A · Trokhan · 2000 [cited by applicant]
US 6193847B1 · Trokhan · 2001 [cited by applicant]
US 6197288B1 · Mankoo · 2001 [cited by applicant]
US 6335180B1 · Julius et al. · 2002 [cited by applicant]
US 6365215B1 · Grainger et al. · 2002 [cited by applicant]
US 6451844B1 · Watkins et al. · 2002 [cited by applicant]
US 6464831B1 · Trokhan et al. · 2002 [cited by applicant]
US 6592884B2 · Hofmann et al. · 2003 [cited by applicant]
US 6660129B1 · Cabell et al. · 2003 [cited by applicant]
US 6673844B2 · Kumamoto et al. · 2004 [cited by applicant]
US 6790629B2 · Julius et al. · 2004 [cited by applicant]
US 6867009B2 · Cortright et al. · 2005 [cited by applicant]
US 6884903B2 · Lorenz et al. · 2005 [cited by applicant]
US 6890567B2 · Nakatsu et al. · 2005 [cited by applicant]
US 6956139B2 · Green et al. · 2005 [cited by applicant]
US 7094320B1 · Phan · 2006 [cited by applicant]
US 7097991B2 · Julius et al. · 2006 [cited by applicant]
US 7128809B2 · Vinson et al. · 2006 [cited by applicant]
US 7132000B2 · Muerner et al. · 2006 [cited by applicant]
US 7166195B2 · Hawes · 2007 [cited by applicant]
US 7186803B2 · Dubin et al. · 2007 [cited by applicant]
US 7189760B2 · Erman et al. · 2007 [cited by applicant]
US 7465581B2 · Bevan et al. · 2008 [cited by applicant]
US 7691229B2 · Vinson et al. · 2010 [cited by applicant]
US 7914649B2 · Ostendorf et al. · 2011 [cited by applicant]
US 7915207B2 · Herdt et al. · 2011 [cited by applicant]
US 7919624B2 · Baraldi et al. · 2011 [cited by applicant]
US D672966S · Sheehan et al. · 2012 [cited by applicant]
US 8461145B2 · Gijsen et al. · 2013 [cited by applicant]
US 8506759B2 · Spitzer et al. · 2013 [cited by applicant]
US 8569505B2 · Codd et al. · 2013 [cited by applicant]
US 8592621B2 · Ley et al. · 2013 [cited by applicant]
US 9044429B2 · Bakes et al. · 2015 [cited by applicant]
US 9340914B2 · Manifold et al. · 2016 [cited by applicant]
US 9427415B2 · Sreekrishna et al. · 2016 [cited by applicant]
US 9937115B2 · Haught et al. · 2018 [cited by applicant]
US 10538881B2 · Wang et al. · 2020 [cited by applicant]
US 10745864B2 · Wang · 2020 [cited by examiner]
US 10745865B2 · Wang · 2020 [cited by examiner]
US 11162224B2 · Wang et al. · 2021 [cited by applicant]
US 11486097B2 · Wang · 2022 [cited by examiner]
US 20020119231A1 · Kumamoto et al. · 2002 [cited by applicant]
US 20030044573A1 · Rasch et al. · 2003 [cited by applicant]
US 20030203196A1 · Trokhan · 2003 [cited by applicant]
US 20040052735A1 · Nakatsu et al. · 2004 [cited by applicant]
US 20040084167A1 · Vinson et al. · 2004 [cited by applicant]
US 20040187226A1 · Muerner et al. · 2004 [cited by applicant]
US 20050238701A1 · Kleinwaechter · 2005 [cited by applicant]
US 20050245407A1 · Ishihara · 2005 [cited by applicant]
US 20050266435A1 · Hackos et al. · 2005 [cited by applicant]
US 20060013837A1 · Haines · 2006 [cited by applicant]
US 20060029628A1 · Kleinwaechter · 2006 [cited by applicant]
US 20060088697A1 · Manifold et al. · 2006 [cited by applicant]
US 20060154886A1 · Weihe et al. · 2006 [cited by applicant]
US 20060204466A1 · Littau et al. · 2006 [cited by applicant]
US 20070036733A1 · Spence et al. · 2007 [cited by applicant]
US 20070137812A1 · Shannon et al. · 2007 [cited by applicant]
US 20070190090A1 · Brown · 2007 [cited by applicant]
US 20070297993A1 · Kindel et al. · 2007 [cited by applicant]
US 20080153845A1 · Palmer et al. · 2008 [cited by applicant]
US 20080175801A1 · Ramji · 2008 [cited by applicant]
US 20080245498A1 · Ostendorf et al. · 2008 [cited by applicant]
US 20080311054A1 · Natsch · 2008 [cited by applicant]
US 20090081153A1 · Scott et al. · 2009 [cited by applicant]
US 20090098213A1 · Tran · 2009 [cited by applicant]
US 20090131302A1 · Pasricha et al. · 2009 [cited by applicant]
US 20090175882A1 · Patapoutian et al. · 2009 [cited by applicant]
US 20100119779A1 · Ostendorf et al. · 2010 [cited by applicant]
US 20100183524A1 · Zielinski et al. · 2010 [cited by applicant]
US 20100278991A1 · Haught et al. · 2010 [cited by applicant]
US 20100297400A1 · Mellin et al. · 2010 [cited by applicant]
US 20100314059A1 · Edwards et al. · 2010 [cited by applicant]
US 20100316615A1 · Kurreck et al. · 2010 [cited by applicant]
US 20110077275A1 · Zielinski et al. · 2011 [cited by applicant]
US 20110104301A1 · Ahern et al. · 2011 [cited by applicant]
US 20110124666A1 · Gijsen et al. · 2011 [cited by applicant]
US 20110178181A1 · Bakes et al. · 2011 [cited by applicant]
US 20110311345A1 · Mcneil · 2011 [cited by applicant]
US 20120082628A1 · Haught · 2012 [cited by applicant]
US 20120088774A1 · Grahek et al. · 2012 [cited by applicant]
US 20120121737A1 · Vielhaber et al. · 2012 [cited by applicant]
US 20130143001A1 · Manifold et al. · 2013 [cited by applicant]
US 20130315843A1 · Haught et al. · 2013 [cited by applicant]
US 20130319625A1 · Mohammadi et al. · 2013 [cited by applicant]
US 20140050675A1 · Zielinski et al. · 2014 [cited by applicant]
US 20150176216A1 · Ostendorf et al. · 2015 [cited by applicant]
US 20150176218A1 · Maladen et al. · 2015 [cited by applicant]
US 20150176220A1 · Ostendorf et al. · 2015 [cited by applicant]
US 20150225903A1 · Jeannot et al. · 2015 [cited by applicant]
US 20150272907A1 · Sreekrishna et al. · 2015 [cited by applicant]
US 20150330030A1 · Dwiggins · 2015 [cited by applicant]
US 20150352801A1 · Margo Moreno · 2015 [cited by applicant]
US 20160090692A1 · Eagles et al. · 2016 [cited by applicant]
US 20160090693A1 · Eagles et al. · 2016 [cited by applicant]
US 20160090698A1 · Sze et al. · 2016 [cited by applicant]
US 20160145809A1 · Hermans et al. · 2016 [cited by applicant]
US 20160158136A1 · Haught et al. · 2016 [cited by applicant]
US 20160331659A1 · Sreekrishna et al. · 2016 [cited by applicant]
US 20180112357A1 · Wang et al. · 2018 [cited by applicant]
US 20180112361A1 · Wang et al. · 2018 [cited by applicant]
US 20180280562A1 · Salaam-Zayid et al. · 2018 [cited by applicant]
US 20200109520A1 · Wang et al. · 2020 [cited by applicant]
US 20200354896A1 · Wang · 2020 [cited by examiner]
US 20220064866A1 · Wang et al. · 2022 [cited by applicant]
US 20220178076A1 · Wang et al. · 2022 [cited by applicant]
US 20230027102A1 · Wang · 2023 [cited by examiner]
CA 2567189A1 · 2005 [cited by applicant]
DE 102006032233A1 · 2008 [cited by applicant]
EP 310299 · 1989 [cited by applicant]
EP 1217106A1 · 2002 [cited by applicant]
EP 1600151B1 · 2008 [cited by applicant]
JP 2006065044A · 2006 [cited by applicant]
JP 2011136953A · 2011 [cited by applicant]
JP 2011205975A · 2011 [cited by applicant]
JP 2012062304A · 2012 [cited by applicant]
JP 2012080840A · 2012 [cited by applicant]
WO 0135768A1 · 2001 [cited by applicant]
WO 2004043169A1 · 2004 [cited by applicant]
WO 2005049553A1 · 2005 [cited by applicant]
WO 2006103401A2 · 2006 [cited by applicant]
WO 2009087242A2 · 2009 [cited by applicant]
WO 2011019342A2 · 2011 [cited by applicant]
WO 2011034868A1 · 2011 [cited by applicant]
WO 2013176897A2 · 2013 [cited by applicant]
WO WO2018081192A1 · 2018 [cited by examiner]
1,8-Cineole Causes Comfortable Cooling Sensationby Concomitant Application With MentholIFSCC 2011 Conference Proceeding Book IFSCC pp. 226-231, 2011. [cited by applicant]
15000 PCT Search Report and Written Opinion for PCT/US2017/058176 dated Jan. 29, 2018, 11 Pages. [cited by applicant]
All Office Actions, U.S. Appl. No. 15/792,811, filed Oct. 25, 2017. [cited by applicant]
All Office Actions; U.S. Appl. No. 15/792,816, filed Oct. 25, 2017. [cited by applicant]
All Office Actions; U.S. Appl. No. 16/707,256, filed Dec. 9, 2019. [cited by applicant]
All Office Actions; U.S. Appl. No. 16/938,123, filed Jul. 24, 2020. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/500,628, filed Oct. 13, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/521,174, filed Nov. 8, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 15/792,824, filed Oct. 25, 2017. [cited by applicant]
All Office Actions; U.S. Appl. No. 15/792,821, filed Oct. 25, 2017. [cited by applicant]
An-Guo Ying,et al., “Green and efficient aza-Michael additions of aromatic amines toα, β-unsaturated ketones catalyzed by DBU based task-specific ionicliquids without solvent” 11 pages. [cited by applicant]
Chambers et al. “Measuring Intracellular Calcium Fluxes in High Throughput Mode”, Combinatorial Chemistry & High Throughput Screening, 2003, 6, D£S. 355-362. [cited by applicant]
Database GNPD [Online]; Mintel; Feb. 28, 2009 (Feb. 28, 2009), Anonymous: “Whitening mouthwash”, retrieved from : YY.˜.YLW.mLfQP.}, Databaseaccession No. 1051335. [cited by applicant]
Fischer et al., “Direct Evidence For Functional TRPVI/TRP AI Heteromers”, Pfluegers Archiv (2014), 466 (12), pp. 2229-2241. [cited by applicant]
Gunthorpe Martin J et al: 11 Peripheral TRPV1 receptors as targets for drug development: new molecules andmechanisms 11, Current Pharmaceutical Design, Benthamscience Publishers Ltd, NL, vol. 14, No. I, Jan. 1, 2008 (Ja… [cited by applicant]
John. Read: “Recent Progress in the Menthone Chemistry”, Chemical Reviews, vol. 7, No. 1, Mar. 1, 1930 (Mar. 1, 1930), pp. 1-50, XP055113072, ISSN: 0009-2665, 001: 10.1021 l cr60025a001. [cited by applicant]
Joris Vriens, Giovanni Appendino, and Bernd Nilius, “Pharmacology of Vanilloid Transient Receptor Potential Cation Channels”, Molecularpharmacology, vol. 75 No. 6 Mar. 18, 2009 pp. 1262-1279. [cited by applicant]
Lam, “Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Cali, initiates neurotransmitter release and promotesdelayed cell death.”, Journal of neurochemistry, 102, … [cited by applicant]
Michele C. Jetter, Mark A Youngman, James J. McNally, Sui-Po Zhang, Adrienne E. Dubin, Nadia Nasserb and Scott L. Dax. N-Isoquinolin-5-yl-N′-aralkyl-urea and -amideantagonists of human vanilloid receptor 1. Bioorganic &… [cited by applicant]
Mihara et al. “The role of flavor and fragrance chemicals inTRPA1 (transient receptor potential cation channel, member A1) activity associated with allergies” dated 2015, 12 pages. [cited by applicant]
Mitchell, Jennifer E. et al. “Expression and characterization of the intracellular vanilloid receptor (TRPVI) in bronchi from patients with chronic cough”, ExperimentalLung Research, vol. 31, No. 3, Apr. 1, 2005, pp. 29… [cited by applicant]
Patricia M. W. Lam, Atticus H. Hainsworth, Graham D. Smith, Davina E. Owen, James Davies and David 0. Lambert. Activation of recombinant human TRPVI receptorsexpressed in SH-SY5Y human neuroblastoma cells increases [Ca2… [cited by applicant]
Pier Giovanni Baraldi et al: “Transient Receptor Potential Ankyrin 1 (TRPAI) Channel as Emerging Target for NovelAnalgesics and Anti-Inflammatory Agents”, Journal of Medicinal Chemistry,vol. 53, No. 14, Jul. 22, 2010 (J… [cited by applicant]
Sadofsky, Laura R. et al., “Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPAI and TRPVI) Co-Expressing Cells.”, Cells2014, vol. 3, No. 2, 2014, pp. 616-626. [cited by applicant]
Sadofsky, LR et al. “Characterisation of a HEK293 cell line permanently coexpressing the cough receptors Transient Receptor Potential Ankyrin 1 and V anilloid 1(TRPAI and TRPVI)”, Pulmomary Pharmacology & Therapeutics, … [cited by applicant]
Sreekrishna et al., “Modulation Of Transient Receptor Potential (TRP) Channels By Chinese Herbal Extracts”, Pulmonary Pharmacology & Therapeutics, 2010, 24(3),p. 8. [cited by applicant]
Takaishi et al., “1,8-cineole, a TRPM8 agonist, is a novel natural antagonistof human TRPA1”, Molecular pain, 8 (86), pp. 1-12, Jan. 1, 2012 (Jan. 1, 2012). [cited by applicant]
Yansong, Zhang et al. “Modulation of Transient Receptor Potential (TRP) Channels by Chinese Herbal Extracts”, Phytotherapy Research, vol. 25, No. 11, Mar. 23, 2011, pp. 1666-1670. [cited by applicant]
All Office Actions; U.S. Appl. No. 18/614,851, filed Mar. 25, 2024. [cited by applicant]
Unpublished U.S. Appl. No. 18/614,851, filed Mar. 25, 2024, to Fei Wang et al. [cited by applicant]
Cited By (3)
US 12,565,737 US 12,715,682 US 12,735,246